High Intensity Focused Ultrasound Therapy Market is expected to reach US$ 879.87 Million by 2031

MRI Guided Focused Ultrasound Therapy Segment Drives High Intensity Focused Ultrasound Therapy Market Growth

According to our new research study named "High Intensity Focused Ultrasound Therapy Market Forecast to 2031 – Global Analysis – by Modality, Application, End User, and Geography," the market was valued at US$ 505.49 million in 2024 and is projected to reach US$ 879.87 million by 2031; it is expected to register a CAGR of 8.3% during 2025–2031. The rising prevalence of chronic diseases and cancer, and soaring preference for noninvasive procedures, are key factors driving the adoption of high intensity focused ultrasound therapy. The integration with artificial intelligence for enhanced precision is projected to bring new high intensity focused ultrasound therapy market trends in the coming years.

High intensity focused ultrasound (HIFU) therapy is a procedure that employs intense ultrasound waves that are tightly focused to wipe out the tissue that is only locally disturbing, mostly tumors or fibroids, without any surgical intervention. Increasing cancer cases, a rising number of patients opting for noninvasive procedures, and technological progress in imaging and targeting are driving the global high intensity focused ultrasound therapy market growth. The increasing patients' knowledge of HIFU treatment as a result of a lesser recovery period and fewer side effects, along with a rapidly growing elderly population, propels its use in oncology and urology departments for the treatment of cancer and urinary tract diseases, thereby contributing to the rising high intensity focused ultrasound therapy market size.

High Intensity Focused Ultrasound Therapy Market, by Region, 2024 (%)

High Intensity Focused Ultrasound Therapy Market Analysis Based on Segmental Evaluation:

Based on modality, the high intensity focused ultrasound therapy market is bifurcated into MRI guided focused ultrasound therapy and ultrasound guided therapy. The MRI guided focused ultrasound therapy segment held a significant high intensity focused ultrasound therapy market share in 2024. The MRI-guided focused ultrasound (MRgFUS) technique is the most precise surgery, relying on the combination of the excellent soft-tissue contrast of magnetic resonance imaging and HIFU's high ablation capacity. This combined technology makes real-time thermography possible, which lets the doctors visualize temperature elevations at the focal point, thus assuring correct aiming and instantaneous treatment modifications. MRgFUS is effective in dealing with complicated anatomies, reducing the collateral damage and opening up to neurology and advanced oncology, the areas where traditional ultrasound guidance cannot reach because of barriers such as bone. Its clinical footprint is a game-changer, especially in neurology. The Exablate Neuro device developed by Insightec has received FDA approval for essential tremor and tremor-dominant Parkinson's disease. By thalamotomy, it forms a lesion in a precise location in the ventral intermediate nucleus of the thalamus, thus alleviating hand tremors in non-responsive patients by as much as 75%.

The geographical scope of the high intensity focused ultrasound therapy market report encompasses an assessment of the market performance in North America, Europe, the Asia Pacific, South America, Central America, the Middle East, and Africa. North America dominated the high intensity focused ultrasound therapy market share in 2024. The rising number of cancer cases, especially of the prostate and breast types, has made it necessary to develop noninvasive treatment options. Thus, HIFU has become a favorable method over the traditional ones. New and better ultrasound imaging and focused ultrasound technology have improved treatment accuracy and outcomes, thus becoming more widely accepted.

The increase in the elderly population in North America, which is more prone to chronic diseases, is a favorable factor in the demand for low-risk therapies such as HIFU. The supportive regulatory frameworks and, for the most part, the increased healthcare spending in the US and Canada, have been the main reasons why the innovative medical technologies have been adopted faster, thus boosting the high intensity focused ultrasound therapy market growth. The rising awareness among patients and health care providers about the advantages of HIFU—such as shorter recovery times, very few side effects, and the possibility of being an outpatient treatment—is pushing the market forward. Partnerships between research institutions and medical device companies are speeding up new product development and commercialization. Finally, the growing number of reimbursement policies for noninvasive procedures in North America is rendering HIFU therapy more accessible.

EDAP TMS SA, Sonablate Corp, Koninklijke Philips NV, CLASSYS Inc., Insightec, Hironic Co. Ltd, FUS Instruments Inc., Chongqing Haifu Medical Technology Co. Ltd, Theraclion, Image Guided Therapy, Verasonics Inc., Lynton Lasers Ltd, WON TECH Co. Ltd., and Jeisys Global are among the leading companies profiled in the high intensity focused ultrasound therapy market report.

Based on modality, the high intensity focused ultrasound therapy market is bifurcated into MRI guided focused ultrasound therapy and ultrasound guided therapy. By application, the market is segmented into breast cancer, prostate cancer, liver cancer, pancreatic cancer, breast lifting and aesthetic application, nipple and areola preservation, post surgical applications, and others. On the basis of end user, the high intensity focused ultrasound therapy market is classified into healthcare facilities, diagnostic imaging centers and research centers. Geographically, the high intensity focused ultrasound therapy market is segmented into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East and Africa (Saudi Arabia, South Africa, the UAE, and the Rest of the Middle East and Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).

Contact Us

Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com